Seeking Alpha

Response Genetics (RGDX) signs a provider contract with Blue Cross and Blue Shield of Illinois...

Response Genetics (RGDX) signs a provider contract with Blue Cross and Blue Shield of Illinois making it easier for physicians in the state to provide access to the company's diagnostic tests which help predict patients' response to cancer therapy. The health plan counts some 7.4M members. Shares +14.57% premarket. (PR)
Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Tools
Find the right ETFs for your portfolio:
Seeking Alpha's new ETF Hub
ETF Investment Guide:
Table of Contents | One Page Summary
Read about different ETF Asset Classes:
ETF Selector

Next headline on your portfolio:

|